↓ Skip to main content

Reassessing the Evidence Hierarchy in Asthma: Evaluating Comparative Effectiveness

Overview of attention for article published in Current Allergy and Asthma Reports, September 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
52 Mendeley
Title
Reassessing the Evidence Hierarchy in Asthma: Evaluating Comparative Effectiveness
Published in
Current Allergy and Asthma Reports, September 2011
DOI 10.1007/s11882-011-0222-7
Pubmed ID
Authors

David Price, Alison Chisholm, Thys van der Molen, Nicolas Roche, Elizabeth V. Hillyer, Jean Bousquet

Abstract

Classical randomized controlled trials are the gold standard in medical evidence because of their high internal validity. However, their necessarily strict design can limit their external validity and the ability to extrapolate these data to real world patients. Therefore, alternatively designed studies may play a complementary role in evaluating the comparative effectiveness of therapies in nonidealized patients in more naturalistic, real world settings. Observational studies have high external validity and can evaluate real world outcomes. Their strength lies in hypothesis generation and testing and in identifying areas in which further clinical trials may be required. Pragmatic trials are designed to maximize applicability of trial results to usual care settings by relying on clinically important outcomes and enrolling a wide range of participants. A combination of these approaches is preferable and necessary.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Tunisia 1 2%
Unknown 50 96%

Demographic breakdown

Readers by professional status Count As %
Other 11 21%
Researcher 9 17%
Student > Master 8 15%
Professor > Associate Professor 3 6%
Professor 3 6%
Other 7 13%
Unknown 11 21%
Readers by discipline Count As %
Medicine and Dentistry 21 40%
Pharmacology, Toxicology and Pharmaceutical Science 7 13%
Nursing and Health Professions 4 8%
Economics, Econometrics and Finance 3 6%
Agricultural and Biological Sciences 1 2%
Other 4 8%
Unknown 12 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2011.
All research outputs
#18,295,723
of 22,651,245 outputs
Outputs from Current Allergy and Asthma Reports
#651
of 802 outputs
Outputs of similar age
#108,214
of 130,159 outputs
Outputs of similar age from Current Allergy and Asthma Reports
#6
of 7 outputs
Altmetric has tracked 22,651,245 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 802 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 130,159 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.